Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease

Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease

Saved in:

Bibliographic Details
Main Authors:	Tomasz J. Ślebioda, Zbigniew Kmieć
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2014/325129
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian Population
by: Lynnette R. Ferguson, et al.
Published: (2009-01-01)

The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy
by: Boel De Paepe, et al.
Published: (2012-01-01)

Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
by: Donatella Comito, et al.
Published: (2012-01-01)

The Role of Macrophages in the Pathogenesis of Inflammatory Bowel Disease
by: YR Mahida
Published: (1993-01-01)

Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease
by: Longgui Ning, et al.
Published: (2019-01-01)

Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease
by: Qingdong Guan, et al.
Published: (2017-01-01)

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease
by: Qingdong Guan
Published: (2019-01-01)

Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target
by: Anna Socha-Banasiak, et al.
Published: (2021-01-01)

Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies
by: Diana-Maria Bunu, et al.
Published: (2019-01-01)

Management of the Pregnant Inflammatory Bowel Disease Patient on Antitumour Necrosis Factor Therapy: State of the Art and Future Directions
by: Yvette PY Leung, et al.
Published: (2014-01-01)

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center
by: Roxana Matran, et al.
Published: (2025-01-01)

Tumour necrosis factor-α polymorphism as one of the complex inherited factors in pemphigus
by: Jolanta Dorota Torzecka, et al.
Published: (2003-01-01)

Interleukin-1, Tumour Necrosis Factor and Treatment of the Septic Shock Syndrome
by: Charles A Dinarello
Published: (1992-01-01)

The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis
by: Piotr Wojdasiewicz, et al.
Published: (2014-01-01)

Sequences of acetyl CoA carboxylase promoter for tumour necrosis factor action
by: Keerang Park, et al.
Published: (1993-01-01)

Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms
by: S. Sipka, et al.
Published: (1995-01-01)

Tumour Necrosis Factor-α Production and Immune Cell Activation in Tuberculous Meningitis
by: C. M. Mastroianni, et al.
Published: (1994-01-01)

Can malaria parasite pathogenesis be prevented by treatment with tumor necrosis factor-alpha?
by: Avner Friedman, et al.
Published: (2013-03-01)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
by: H. Tchorzewski, et al.
Published: (1993-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease
by: Daniel C Sadowski, et al.
Published: (2009-01-01)

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated with Etanercept – A Tumour Necrosis Factor-Alpha Antagonist
by: C Nash, et al.
Published: (2001-01-01)

Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review
by: Pan J, et al.
Published: (2025-01-01)

Risk factors for inflammatory bowel disease: an umbrella review
by: Tingping Wu, et al.
Published: (2025-01-01)

Systematic expression analysis of cysteine‐rich secretory proteins, antigen 5, and pathogenesis‐related 1 protein (CAP) superfamily in Arabidopsis
by: Megumi Matsuzawa, et al.
Published: (2024-10-01)

Inhibition of tumour necrosis factor alpha by Etanercept attenuates Shiga toxin-induced brain pathology
by: Robin Christ, et al.
Published: (2025-02-01)

Evaluation of Tumour Necrosis Factor Alpha, Interleukin-2 Soluble Receptor, Nitric Oxide Metabolites, and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus
Published: (2006-01-01)

Vertebrate TNF Superfamily: Evolution and Functional Insights
by: Ignacio Marín
Published: (2025-01-01)

Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997-01-01)

Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01)

Autoimmunity in Inflammatory Bowel Disease
by: Kiron M Das
Published: (1993-01-01)

Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997-01-01)

Immunopathogenesis of inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2013-09-01)

Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)

A Nomogram Based on Laboratory Data, Inflammatory Bowel Disease Questionnaire and CT Enterography for Activity Evaluation in Crohn’s Disease
by: Zhang H, et al.
Published: (2025-01-01)

Effect of Exercise Training on Interleukin-6, Tumour Necrosis Factor Alpha and Functional Capacity in Heart Failure
by: Neil A. Smart, et al.
Published: (2011-01-01)

Effects of acute cigarette smoke exposure on macrophage kinetics and release of tumour necrosis factor α in rats
by: G. P. Pessina, et al.
Published: (1993-01-01)

Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor
by: M. Romano, et al.
Published: (1997-01-01)

Assessing inflammatory protein factors in inflammatory bowel Disease using multivariable mendelian randomization
by: Qiang Su, et al.
Published: (2025-01-01)

On the Pathogenesis of the Irritable Bowel Syndrome: The Irritable Bowel or the Irritable Patient?
by: Stephen M Collins
Published: (1990-01-01)

Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease
by: Chang-Hung Liao, et al.
Published: (2025-01-01)